The 1,4-benzothiazepine JTV519 inhibited diastolic SR Ca2+ leak, monophasic action potential alternans, and triggered arrhythmias in calstabin-2-deficient mice.
Does JTV519 prevent diastolic SR Ca2+ leak and arrhythmias in calstabin-2-deficient mice?
JTV519 stabilizes the cardiac ryanodine receptor by increasing calstabin-2 binding affinity, preventing intracellular calcium leak and triggered arrhythmias in a mouse model.
Catecholaminergic polymorphic ventricular tachycardia is a form of exercise-induced sudden cardiac death that has been linked to mutations in the cardiac Ca2+ release channel/ryanodine receptor (RyR2) located on the sarcoplasmic reticulum (SR). We have shown that catecholaminergic polymorphic ventricular tachycardia-linked RyR2 mutations significantly decrease the binding affinity for calstabin-2 (FKBP12.6), a subunit that stabilizes the closed state of the channel. We have proposed that RyR2-mediated diastolic SR Ca2+ leak triggers ventricular tachycardia (VT) and sudden cardiac death. In calstabin-2-deficient mice, we have now documented diastolic SR Ca2+ leak, monophasic action potential alternans, and bidirectional VT. Calstabin-deficient cardiomyocytes exhibited SR Ca2+ leak-induced aberrant transient inward currents in diastole consistent with delayed after-depolarizations. The 1,4-benzothiazepine JTV519, which increases the binding affinity of calstabin-2 for RyR2, inhibited the diastolic SR Ca2+ leak, monophasic action potential alternans and triggered arrhythmias. Our data suggest that calstabin-2 deficiency is as a critical mediator of triggers that initiate cardiac arrhythmias.
Lehnart et al. (Thu,) conducted a other in Catecholaminergic polymorphic ventricular tachycardia. 1,4-benzothiazepine JTV519 was evaluated on Diastolic SR Ca2+ leak, monophasic action potential alternans, and triggered arrhythmias. The 1,4-benzothiazepine JTV519 inhibited diastolic SR Ca2+ leak, monophasic action potential alternans, and triggered arrhythmias in calstabin-2-deficient mice.